Search
SOLACI Congress
HomeFile

File

View Category
Structural heart disease

When Is the Optimal Time for Aortic Valve Replacement? Impact of Acute Valvular Syndrome on Outcomes and Costs

According to the clinical presentation before aortic valve replacement (AVR), a new classification has recently been proposed:...
Dr. Juan Manuel Pérez -
Learn More
Coronary disease

Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium

The use of drug-coated balloons (DCB) is emerging as one of the most promising strategies in coronary...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the...
Dr. Omar Tupayachi -
Learn More
Coronary disease

Use of Drug-Coated Balloons in Chronic Total Occlusions: The ERCTO Registry

Chronic total coronary occlusions (CTO) are still a major challenge in interventional cardiology, affecting 16%–18% of patients...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

In Hospital Complications after Transcatheter Aortic Valve Replacement in Bicuspid vs. Tricuspid Aortic Valves: A Retrospective Cohort Study

Courtesy of Dr. Juan Manuel Pérez.  Bicuspid aortic valves (BAV), present in 0,5 to 2% of the population,...
Dr. Juan Manuel Pérez -
Learn More
Coronary disease

Treatment of Femoropopliteal Lesions with Drug-Coated Balloons: IVUS vs. Conventional Angiography

Angiography has traditionally been the standard imaging technique to guide endovascular therapy (EVT) in patients with peripheral...
Dr. Andrés Rodríguez -
Learn More
Arterial Accesses

Use of Distal Radial Access for Recanalization of Radial Occlusions

Transradial access (TRA) is the preferred route for most percutaneous coronary procedures, with proven benefits in reducing...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Is the Acceleration Time/Ejection Time Ratio Superior to the Mean Gradient in Predicting Clinical Outcomes After TAVR?

Courtesy of Dr. Juan Manuel Pérez. Traditionally, the mean gradient (MG) has been used to assess post-TAVR outcomes....
Dr. Juan Manuel Pérez -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy